Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
09:59
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

13th International Conference on Malignant Lymphoma

 

17-20 June 2015 Lugano
FAQs
   
Discussion forum - 13th International Conference on Malignant Lymphoma
    Topic - Ongoing trials

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 181
Visits: 66
Title: First in-patient proof of safety and efficacy of a 4th generation chimeric antigen receptor-modified T cells for the treatment of R/R CD30-positive lymphoma
Authors: Zhitao Ying ,
Centre: Peking University Cancer Hospital

You must be registered to reply or comment.

FIRST IN-PATIENT PROOF OF SAFETY AND EFFICACY OF A 4TH GENERATION CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS FOR THE TREATMENT OF R/R CD30-POSITIVE LYMPHOMA

Zhitao Ying
Thread initiator
Subspeciality
Reg: 6/8/2015 6:11:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 6/8/2015 6:11:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center

Poster most viewed in this topic
Poster: 14
Visits: 271
Title: CLLR3 A randomized Phase II trial evaluating the chemotherapies FC/ B combined with GA101 followed by GA101 maintenance in relapsed/ refractory CLL
Authors: Nadine Kutsch ,
Centre: University Hospital of Cologne


 




PosterSessionOnline
Logo Draft
 
Logo Cert